Liposarcoma: Molecular Genetics and Therapeutics
2011

Liposarcoma: Molecular Genetics and Therapeutics

Sample size: 163 publication Evidence: moderate

Author Information

Author(s): Rachel Conyers, Sophie Young, David M. Thomas

Primary Institution: Peter MacCallum Cancer Centre

Conclusion

The study highlights the molecular characteristics of liposarcoma and suggests potential strategies for therapeutic intervention.

Supporting Evidence

  • Liposarcomas constitute 20% of soft tissue and bone sarcomas diagnosed in 2009 in America.
  • Chemotherapy sensitivity varies considerably between liposarcoma subtypes.
  • 23% of tumors were reclassified based on cytogenetic information in a recent study.

Takeaway

Liposarcoma is a type of cancer with different forms, and understanding its genetics can help find better treatments.

Methodology

The study involved a review of molecular genetics and therapeutic strategies for liposarcoma.

Limitations

The study is limited by the complexity and rarity of liposarcoma subtypes.

Participant Demographics

The study references data from patients diagnosed with liposarcoma, particularly in the USA.

Digital Object Identifier (DOI)

10.1155/2011/483154

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication